The global Chlamydia infection diagnostics and therapeutics market is witnessing steady growth, driven by rising prevalence of sexually transmitted infections (STIs) and continuous advancements in diagnostic technologies. Valued at US$ 1.1 Bn in 2023, the market is projected to reach US$ 2.3 Bn by 2034, expanding at a CAGR of 6.9% from 2024 to 2034. Increasing awareness about early diagnosis...